Cipher Pharmaceuticals Inc. (TSX:CPH)
14.80
+0.48 (3.35%)
Oct 31, 2025, 4:00 PM EDT
Cipher Pharmaceuticals Revenue
Cipher Pharmaceuticals had revenue of $13.38M USD in the quarter ending June 30, 2025, with 152.28% growth. This brings the company's revenue in the last twelve months to $47.59M, up 114.78% year-over-year. In the year 2024, Cipher Pharmaceuticals had annual revenue of $33.36M with 57.66% growth.
Revenue (ttm)
$47.59M
Revenue Growth
+114.78%
P/S Ratio
5.60
Revenue / Employee
$9.52M
Employees
5
Market Cap
363.29M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.36M | 12.20M | 57.66% |
| Dec 31, 2023 | 21.16M | 487.00K | 2.36% |
| Dec 31, 2022 | 20.68M | -1.27M | -5.78% |
| Dec 31, 2021 | 21.94M | 336.00K | 1.56% |
| Dec 31, 2020 | 21.61M | -844.00K | -3.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.75B |
| dentalcorp Holdings | 1.62B |
| Trulieve Cannabis | 1.62B |
| Green Thumb Industries | 1.57B |
| Extendicare | 1.51B |
| Verano Holdings | 1.16B |
| WELL Health Technologies | 1.12B |
| Sienna Senior Living | 929.68M |
Cipher Pharmaceuticals News
- 25 days ago - Halvio Capital Q3 2025 Position Updates - Seeking Alpha
- 3 months ago - Cipher Pharmaceuticals Inc. (CPHRF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue - Benzinga
- 6 months ago - Cipher Pharmaceuticals Inc. (CPHRF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Cipher Pharmaceuticals GAAP EPS of $0.10, revenue of $12M - Seeking Alpha
- 6 months ago - Most Topical Earnings Summaries And Commentary For April 2025 - Seeking Alpha
- 7 months ago - Cannabis Stock Gainers And Losers From March 27, 2025 - Benzinga
- 8 months ago - Cipher Pharmaceuticals Inc (CPHRF) Q4 2024 Earnings Call Highlights: Record Revenue Surge and ... - GuruFocus